Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award

Matt Tremblay, Ph.D., Chief Operating Officer of the California Institute of Biomedical Research (Calibr) and Vice President of Business Development at The Scripps Research Institute (TSRI), has been named one of Biocom Inc.’s annual Life Science Catalyst Award winners.

The Life Science Catalyst Awards, presented by Biocom in conjunction with the San Diego Venture Group, recognizes 10 accomplished and up-and-coming academics, entrepreneurs, investors, corporate leaders and business advisers making a mark on San Diego’s life science industry before reaching their 40th birthday. 

“Matt’s scientific contributions and business leadership played an important role in establishing Calibr and creating the new model for translational research and innovation represented by the affiliation with TSRI,” said Peter G. Schultz, Ph.D., Chief Executive Officer of both institutes.

Tremblay, now 37, was among the first employees hired by Schultz to help start Calibr in 2012.  He was initially hired to lead a team of biologists in the company’s drug discovery efforts, but quickly became involved in the day-to-day operations and was promoted in rapid succession to his current role as Chief Operating Officer.  Following Calibr’s merger with TSRI in October 2016, Tremblay took on an added role as TSRI’s Vice President for Business Development.

“I’m honored to be recognized with this award and to be part of such a vibrant, innovative life science community here in San Diego,” Tremblay said.

This marks the second year TSRI faculty have been recognized by Biocom for their leadership, innovation and contributions to life sciences.  Last year, TSRI Chemistry Professor Phil Baran received one of the 10 inaugural Life Science Catalyst Awards.

For more information, contact press@scripps.edu See More News